HCV Next: Physicians Diagnosing,Treating HCV Define New Role in Opioid Crisis

Check out the July/August issue of HCV Next, just released online at Healio. 

Table of Contents

Cover Story 
Physicians Diagnosing,Treating HCV Define New Role in Opioid Crisis

The opioid epidemic in the United States has affected millions, exposing them to health risks that include a range of infectious diseases.

Feature

Point-of-Care HCV Assays: A Turning Point for Decentralized Diagnosis

Compared with traditional hepatitis virological tests, the benefit of point-of-care diagnostics is their use in patient care sites such as outpatient clinics, intensive care units, emergency departments and medical laboratories. Additionally, certain low- and middle-income countries have made use of point-of-care tests in blood banks.

In the Journals Plus

Most iatrogenic HCV cases unidentified until symptom onset
Insurance denials for HCV therapy increase in US

Meeting News
HCV outcomes worse for patients with public insurance, Medicaid
Homeless veterans with HCV diagnosed, treated via PCP outreach

Trend Watch

AASLD online HCV guide update includes key at-risk populations

Begin here.....

On This Blog
The controversy over expensive new drugs for hepatitis C
Link to research and news articles addressing the high cost of hepatitis C drugs; insurance restrictions - private insurers/Medicaid - and availability of generic versions.

Elsewhere
Efficacy of Generic Oral DAAs in Patients With HCV Infection
Journal of Viral Hepatitis, July 20, 2018